[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360090-105":59,"doc-detail-360090-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","therapeutic-efficacy-of-cancer-stem-cell-based-vaccine-in-colorectal-murine-model-reduced-tumor-growth-and-prolonged-survival","Therapeutic efficacy of cancer stem cell-based vaccine in colorectal murine model - reduced tumor growth and prolonged survival","","Background Various forms of cancer immunotherapy are promising against resistance to conventional chemo- and radiotherapy. Cancer vaccines may complement standard care by reducing relapse and mortality. This study developed a therapeutic colorectal cancer stem cell (CSC)-based vaccine to determine whether vaccination inhibits tumor formation and improves survival in a mouse model. Methods CSCs were enriched from CT-26 and characterized, then mice were immunized and assessed by tumor growth, survival, histology, flow cytometry, and immunofluorescence. Results showed delayed formation, reduced growth, stronger immune responses, and improved survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/therapeutic-efficacy-of-cancer-stem-cell-based-vaccine-in-colorectal-murine-model-reduced-tumor-growth-and-prolonged-survival/360090/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/therapeutic-efficacy-of-cancer-stem-cell-based-vaccine-in-colorectal-murine-model-reduced-tumor-growth-and-prolonged-survival/360090.png","ImageObject",300,407,{"name":92,"@type":93},"Putri","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study target in colorectal cancer treatment?","Question",{"text":112,"@type":113},"It addresses obstacles caused by resistance to conventional chemo- and radiotherapy and the role of cancer stem cells in recurrence and metastasis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were cancer stem cells prepared for the vaccine?",{"text":117,"@type":113},"CSCs were enriched from the CT-26 cell line using a sphere formation assay, then characterized with real-time q-PCR for stemness genes and tumorigenesis assays in syngeneic BALB/c mice.",{"name":119,"@type":110,"acceptedAnswer":120},"What outcomes did the CSC lysate-based vaccine produce in mice?",{"text":121,"@type":113},"Immunization delayed tumor formation, reduced tumor growth rate, improved survival, and increased antibody responses against CSCs and parental cells, supported by flow cytometry and immunofluorescence findings.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360090,1791623623,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Hashemi et al. BMC Cancer (2026) 26:614 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15925-3](https://doi.org/10.1186/s12885-026-15925-3)  \nRESEARCH Open Access  \nTherapeutic efficacy of cancer stem cell-based  vaccine in colorectal murine model: reduced tumor growth and prolonged survival  \nFarideh Hashemi 1,2, Masoumeh Dehghan Manshadi 1,2, Sadegh Safaei1,2, Hossein Aminianfar3,  \nMahmood Bozorgmehr 1,4, Leila Eini5, Ahmad Shariftabrizi6, Mahdieh Razmi 1, Marzieh Naseri 1,7, Roya Ghods1,2* and Zahra Madjd1,2*  \nAbstract  \nBackground Various forms of cancer immunotherapy are promising in overcoming the obstacles posed by resistance to conventional chemo-and radiotherapy. Cancer vaccines could serve as beneficial adjuncts to conventional therapies, offering the potential for fine-tuning to reduce relapse and related mortality. Continuing prior investigations, a therapeutic colorectal cancer stem cell (CSC)-based vaccine was developed to explore whether this vaccination could inhibit the formation and prolong survival rates in a mouse model of colorectal cancer.  \nMethods CSCs were enriched from the CT-26 cell line using sphere formation assay and characterized by real-time q-PCR for stemness genes (Oct4, Sox2, and Nanog) and tumorigenesis assay in syngeneic BALB/c mice. Different groups of mice were intraperitoneally immunized with the CSC lysate-based vaccine, the parental cell lysate-based vaccine, and control groups following subcutaneous challenge with CT-26 cells. Beyond analyzing tumor growth and survival rates, histological analysis of tumor tissues was conducted using comprehensive hematoxylin and eosin (H&E) staining, and antibody responses in vaccinated mice were evaluated by flow cytometry and immunofluorescence. Results Immunization of tumor-bearing mice with the CT-26 CSC lysate-based vaccine caused delayed tumor formation, reduced tumor growth rate, and enhanced survival rate compared to the control groups. The histological responses observed in the lysate vaccination subgroups indicated a potent immune response. Furthermore, flow cytometry and immunofluorescence analyses demonstrated the production of anti-CSC and anti-parental cell antibodies in mice immunized with CT-26 CSC and parental cell lysates.  \nConclusion These findings suggest that targeting CSCs using a CSC lysate-based vaccine can stimulate cellular and humoral immunity and represent a novel therapeutic approach to complement conventional antitumor therapies. Keywords Cancer stem cells (CSCs), Therapeutic CSC-based vaccine, Colorectal murine model, Tumor growth, Survival rates  \n*Correspondence:  \nRoya Ghods  \n[rghods77@yahoo.com](rghods77@yahoo.com); [ghods. ro@iums.ac.ir](ghods. ro@iums.ac.ir)[ ](ghods. ro@iums.ac.ir)Zahra Madjd  \n[Zahra.madjd@yahoo.com](Zahra.madjd@yahoo.com); [majdjabari.z@iums.ac.ir](majdjabari.z@iums.ac.ir)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nHashemi et al. BMC Cancer (2026) 26:614 Page 2 of 21  \nGraphical abstract  \nAn overview of ","cbCaiiTbRwOt5TeA","https://ap.wps.com/l/cbCaiiTbRwOt5TeA","pdf",8923199,21,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Significance statement\n# Introduction","[{\"question\":\"What problem does the study target in colorectal cancer treatment?\",\"answer\":\"It addresses obstacles caused by resistance to conventional chemo- and radiotherapy and the role of cancer stem cells in recurrence and metastasis.\"},{\"question\":\"How were cancer stem cells prepared for the vaccine?\",\"answer\":\"CSCs were enriched from the CT-26 cell line using a sphere formation assay, then characterized with real-time q-PCR for stemness genes and tumorigenesis assays in syngeneic BALB/c mice.\"},{\"question\":\"What outcomes did the CSC lysate-based vaccine produce in mice?\",\"answer\":\"Immunization delayed tumor formation, reduced tumor growth rate, improved survival, and increased antibody responses against CSCs and parental cells, supported by flow cytometry and immunofluorescence findings.\"}]","Therapeutic efficacy of cancer stem cell-based vaccine in colorectal murine model - reduced tumor growth and prolonged survival | PDF",1790138729,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/352b67fda189bc41f1afe1d8f186ff6e.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0c93f7c775613b2bdf2ea4ea90d2714.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/199a361f6426854f617b08fc6256aef6.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4a97e1bc8c92f3b0c962ab9236fb033.webp",980,1306]